Helen Sabzevari, President, Precigen, Inc at INTREXON CORP (XON), sold 3,832 shares at $7.07 ($27K) on 2019-01-03, disclosed to the SEC on 2019-01-04.
Scheduled sale ($27k) by President, Precigen, Inc under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PGEN | SELL | 2023-08-25 | $236K | — | Filing → |
| PGEN | SELL | 2023-08-18 | $185K | — | Filing → |
| PGEN | SELL | 2023-08-11 | $119K | — | Filing → |